Target intelligence / Profile preview

Esophageal mucosal surface and luminal irritants

Molecular classification
Other
01

Overview

The esophageal mucosal surface and luminal irritants represent the physiological and pathological interface involved in esophageal health and disease (StatPearls, 2023). The esophageal mucosa serves as a critical barrier against luminal irritants such as gastric acid, pepsin, and bile salts, which can reflux from the stomach (Nature Reviews Disease Primers, 2017). This defense system is organized into pre-epithelial, epithelial, and post-epithelial layers that maintain tissue integrity (PubMed, 2000). When the balance between these protective factors and the aggressive luminal irritants is disrupted, it results in mucosal injury, inflammation, and symptoms of gastroesophageal reflux disease (GERD) (NIH, 2020). Pharmacological management focuses on either reducing the acidity and volume of the luminal irritants or providing a physical coating to reinforce the mucosal surface (PubChem, 2024). Understanding this interface is essential for developing treatments that prevent the progression of esophagitis to more severe conditions like Barrett's esophagus (Mayo Clinic, 2023).

Other names
Esophageal mucosaGastric refluxateEsophageal barrierAcid and pepsinBile salts
02

Mechanism of action

Neutralization of luminal acid, inhibition of gastric acid secretion, and formation of a physical protective barrier over the mucosal surface.

03

Biological functions

Barrier functionAcid-base homeostasisTissue protection
04

Disease associations

Gastroesophageal reflux diseaseEsophagitisBarrett's esophagusEsophageal adenocarcinoma
05

Safety considerations

Malabsorption of mineralsIncreased risk of enteric infectionsRebound acid hypersecretion
06

Interacting drugs

Omeprazole

7 more in the full profile.

07

Biomarkers

Esophageal pHEndoscopic mucosal appearanceTransepithelial electrical resistance (TEER)

Beyond the preview

Go deeper on Esophageal mucosal surface and luminal irritants.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esophageal mucosal surface and luminal irritants.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call